Close

News

April 27, 2017
​SMEs discover the potential of the Barcelona Synchrotron Park
The 20-person delegation representing different SMEs from the cities of Granollers and Montmeló that visited this week the ALBA synchrotron could see how this singular facility does not only serve the international scientific community: this electron accelerator that produces radiations used to observe the inner structure of materials is an infrastructure also useful and accessible to companies.

Actually, the ALBA industrial liaison office aims precisely at making companies know and use the wide range of unique material characterization tools ALBA offers to improve industrial processes and develop new products in very different sectors such as food, health, energy or nanotechnology.

The delegation also had the opportunity to discover the polygeneration power plant (photo): in order to reduce the environmental impact of its urban development, the Barcelona Synchrotron Park has designed and built a centralized heating and cooling system based on high efficiency polygeneration technologies that allow the simultaneous production of electricity (for ALBA) and heating and cooling distributed throughout the park. This approach helps reduce primary consumption and CO2 emission by 35% compared to conventional air-conditioning systems installed in each company.

This outsourced service allows companies to concentrate on their business, reduce their initial investment and the physical space to allocate to bulky equipment, reduce of some 20% the associated operating and maintenance costs and give flexibility if energy requirements change.
April 18, 2017
​Stradivarius has settled in the Barcelona Synchrotron Park
The Stradivarius staff of 350 people has just taken possession of the new headquarters built in the Barcelona Synchrotron Park (BSP): Great news for BSP!
 
Thinking about a location, Stradivarius wanted a place near Barcelona, well connected to the city, a place that enhances the new building to be constructed and that offers an inspiring setting for the designers and all the team that make Stradivarius the well-known creative international clothing fashion brand that presents its collections in about 1,000 boutiques in more than 60 countries around the world.
 
Welcome to BSP!
April 05, 2017
The BSP is candidate to host the European Medicines Agency
Due to the Brexit, the European Medicines Agency (EMA) currently settled in London will have to be transferred in a new town of the EU-27.
Barcelona, with the support of the Spanish government, is candidate to host the agency and the Barcelona Synchrotron Park (BSP) presents its offer to build the EMA’s headquarters in the park.
This candidature presented during the Àmbit B30 association board on April 6 2017 is the candidature of a whole region, the Vallès, in the Barcelona Metropolitan Area.
The candidature file can be downloaded in Spanish or Catalan.
 
March 30, 2017
ALBA Synchrotron Gives Support to Companies
The meeting organized this month at ALBA synchrotron with representatives from the Industrial Liaison Offices of different European synchrotrons offers an opportunity to remind that a synchrotron does not only serve the international scientific community but also companies, both large ones and SMEs, allowing them to stimulate their innovation and so their competitiveness.

The ALBA industrial liaison office, under Alejandro Sánchez’s responsibility, aims precisely at making corporate world know the wide range of unique material characterization tools ALBA offers to improve industrial processes and develop new products in very different sectors such as food, health, energy or nanotechnology.

As a one-stop shop, the industrial liaison office provides advice and services to the industrial community during their time at the ALBA Synchrotron and helps in knowledge transfer activities.
March 21, 2017
Barcelona Synchrotron Park Sponsors the Sixth Ideas Generation Program
The Ideas Generation Program organized by PRUAB, the UAB University research park, is an original initiative supported by Barcelona Synchrotron Park that sponsors the top prize: every year, it aims at offering companies the benefit of the UAB researchers’ wealth of creativity to get proposals to their technological challenges.

This program is based on: 1) Collecting technology challenges posed by local companies from a given sector, 2) Inspiring solutions from the UAB scientific community, 3) Training researchers to help them make their proposal a reality (assessment to elaborate a business plan, create a start-up etc.), 4) Evaluating these projects by experts, 5) Rewarding the best projects.
 
In the last five editions focused on ICT technologies, biotechnologies, environment, aerospace and culture sectors, respectively, 60 projects have been generated and 9 of them have been transformed into currently operative companies that could get a global amount of 1 million euros founds.
 
Barcelona Synchrotron Park supports this initiative that helps the economic development of the local territory and sponsors the sixth program, which this year is devoted to the biotechnology industry and biomedicine. This new edition starts now and will conclude on November 30 with the awards ceremony.
March 16, 2017
​A new class of inhibitors against pain investigated at the ALBA synchrotron
The pharmaceutical company ESTEVE (2,470 people, 916 million Euros income in 2016), the Universitat Autònoma de Barcelona (UAB) and the ALBA Synchrotron joined together to investigate the mechanism of action of new inhibitors against pain developed by the company.

Getting new information about the interactions, active site and mechanism of action of the developed drugs and the therapeutic target may help to the better understanding of the effects of the inhibitors and can provide key information to improve their properties. In that sense, the XALOC ALBA beam line offers a valuable tool for carrying out the corresponding experiments.

As a first step, the research will be carried out at the Protein Production Platform of the UAB to obtain the pure protein complexed with the inhibitors. Secondly, X-ray crystallography studies will be performed at the biolab and in ALBA.

This project is a good example of public-private collaboration that fosters the synergies and relationships between the industrial and academic sectors to advance research and innovation.
1 2 3 4 5 6 7 8